Twitter with OTEurope

Article

It would probably be safe to assume that everyone reading this piece will have at least heard of Twitter; even if they are not actually using it. However, knowing that Twitter is out there and using it effectively are two very different things.

It would probably be safe to assume that everyone reading this piece will have at least heard of Twitter; even if they are not actually using it. However, knowing that Twitter is out there and using it effectively are two very different things.

www.twitter.com/oteurope will take you to Ophthalmology Times Europe's Twitter page and allows you to keep in touch with people and exchange information. Twitter is a microblogging platform that is increasingly being used as a business communication channel. It has different uses for different people but we think its value probably lies in a combination of broadcasting information and engaging in conversations with others.

It is a powerful medium to use for communicating with friends, colleagues and communities with shared interests. There are over three million registered users including ophthalmologists. We hope you find it useful and another method of keeping in touch with the ophthalmic community.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.